Drug Shortage Report for CODEINE PHOSPHATE INJECTION USP

Last updated on 2022-04-20 History
Report ID 158706
Drug Identification Number 00544884
Brand name CODEINE PHOSPHATE INJECTION USP
Common or Proper name CODEINE PHOSPHATE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) CODEINE PHOSPHATE
Strength(s) 30MG
Dosage form(s) LIQUID
Route of administration SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR
Packaging size 1ML 10LIAM
ATC code R05DA
ATC description COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-04-12
Estimated end date Unknown
Actual end date 2022-04-20
Shortage status Resolved
Updated date 2022-04-20
Company comments Discontinued
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2022-04-20 French Compare
v3 2022-04-20 English Compare
v2 2022-04-13 French Compare
v1 2022-04-13 English Compare

Showing 1 to 4 of 4